casgevy approval

  1. New Hope for Sickle Cell Patients as NHS Rolls Out Casgevy Treatment

    Europe New Hope for Sickle Cell Patients as NHS Rolls Out Casgevy Treatment

    The NHS has approved Casgevy, a groundbreaking gene-editing treatment for sickle cell disease, offering hope to thousands. Expected to help 50 patients annually, the £1.65 million therapy corrects faulty genes, significantly reducing hospital visits. The treatment will be available at NHS...
Back
Top